Erythropoietins: A common mechanism of action

作者: Steve Elliott , Elizabeth Pham , Iain C. Macdougall

DOI: 10.1016/J.EXPHEM.2008.08.003

关键词: Epoetin alfaMechanism of actionPharmacologyErythropoietinErythropoiesisMedicineAnemiaDarbepoetin alfaRed blood cellPEGylation

摘要: … mechanism but more prolonged action. Darbepoetin alfa is a hyperglycosylated EPO analog with an extended terminal half-life and a greater relative potency compared with rhEPO at …

参考文章(106)
CA Finch, LA Harker, JD Cook, Kinetics of the formed elements of human blood. Blood. ,vol. 50, pp. 699- 707 ,(1977) , 10.1182/BLOOD.V50.4.699.BLOODJOURNAL504699
Erslev Aj, Erythropoietin titers in health and disease. Seminars in Hematology. ,vol. 28, pp. 2- ,(1991)
VC Broudy, N Lin, M Brice, B Nakamoto, T Papayannopoulou, Erythropoietin receptor characteristics on primary human erythroid cells Blood. ,vol. 77, pp. 2583- 2590 ,(1991) , 10.1182/BLOOD.V77.12.2583.2583
A.J. Erslev, J. Wilson, J. Caro, Erythropoietin titers in anemic, nonuremic patients. Journal of Laboratory and Clinical Medicine. ,vol. 109, pp. 429- 433 ,(1987) , 10.5555/URI:PII:0022214387901156
Steven G. Elliott, New molecules and formulations of recombinant human erythropoietin Birkhäuser Basel. pp. 241- 258 ,(2003) , 10.1007/3-7643-7543-4_15
Anne C. Heatherington, Clinical pharmacokinetic properties of rHuEPO: a review Birkhäuser Basel. pp. 87- 112 ,(2003) , 10.1007/3-7643-7543-4_6